Uri Napchan is a Neurology physician. OpenAlex indexes 10 publications with 797 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
21 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
86.7%Neuromuscular Blocker86.7%Onabotulinumtoxina100%Botox0%Part D + Part B≥41 patientsCentral alpha-2 Adrenergic Agonist0.1%Tizanidine Hcl100%Part D<11 patientsNervous system
12.6%Calcitonin Gene-related Peptide Antagonist7.2%Eptinezumab-jjmr99%Vyepti1%Part D + Part B<11 patientsCalcitonin Gene-related Peptide Receptor Antagonist1.3%Nurtec Odt36%Qulipta33%Ubrelvy31%Part D≥32 patients+ 14 more classes in this area
Cardiovascular
0.3%Beta blocker0.2%Propranolol Hcl Er77%Propranolol Hcl23%Part D<11 patientsCalcium channel blocker0.1%Verapamil Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”